1. 16S metagenomic assessment of the skin microbiota dynamic and possible association with the risk of infection in patients with epidermal necrolysis. (18th August 2021) Authors: Lavaud, J.; Hüssler, S.; Gricourt, G.; de Prost, N.; Rodriguez, C.; Ingen‐Housz‐Oro, S.; Chosidow, O.; Bernigaud, C.; Woerther, P.L. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 12(2021) Page Start: e914 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antiphospholipid Autoantibodies and Thrombosis in Patients With COVID‐19: Comment on the Article by Bertin et al. Issue 5 (16th March 2021) Authors: Frapard, T.; Hue, S.; Rial, C.; de Prost, N.; Mekontso Dessap, A. Journal: Arthritis & rheumatology Issue: Volume 73:Issue 5(2021) Page Start: 897 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Axonal Guillain‐Barré syndrome and toxic epidermal necrolysis: two cases. (28th December 2021) Authors: Weill, A.; Demeret, S.; Ingen‐Housz‐Oro, S.; Colin, A.; Bagate, F.; de Prost, N.; Weiss, N. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 5(2022) Page Start: e373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Calcinosis cutis in epidermal necrolysis: role of caspofungin?. (18th November 2021) Authors: Colboc, H.; Bettuzzi, T.; Badrignans, M.; Bazin, D.; Boury, A.; Letavernier, E.; Frochot, V.; Tang, E.; Moguelet, P.; Ortonne, N.; de Prost, N.; Ingen‐Housz‐Oro, S. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 4(2022) Page Start: e313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Carrying out local care for epidermal necrolysis: survey of practices. (7th October 2020) Authors: Ingen‐Housz‐Oro, S.; Le Floch, R.; Alves, A.; Colin, A.; Ouedraogo, R.; Welfringer, A.; Dereure, O.; Besnard, N.; Bodemer, C.; Bernier, C.; Hoffmann, C.; Tétart, F.; Carpentier, D.; Cordel, N.; Elie, E.; Tauber, M.; Soubiron, L.; Milpied, B.; de Prost, N. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 2(2021) Page Start: e155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Chronic pain: a long‐term sequela of epidermal necrolysis (Stevens–Johnson syndrome/toxic epidermal necrolysis) – prevalence, clinical characteristics and risk factors. (22nd September 2020) Authors: Lefaucheur, J.‐P.; Valeyrie‐Allanore, L.; Ng Wing Tin, S.; Abgrall, G.; Colin, A.; Hajj, C.; de Prost, N.; Wolkenstein, P.; Ingen‐Housz‐Oro, S.; Chosidow, O. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 1(2021) Page Start: 188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Disabling ocular sequelae of epidermal necrolysis: risk factors during the acute phase and associated sequelae. (1st August 2019) Authors: Hajj, C.; Ezzedine, K.; Thorel, D.; Delcampe, A.; Royer, G.; Hua, C.; Colin, A.; de Prost, N.; Muraine, M.; Chosidow, O.; Wolkenstein, P.; Gueudry, J.; Ingen‐Housz‐Oro, S. Journal: British journal of dermatology Issue: Volume 181:Number 2(2019) Page Start: 421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Disabling ocular sequelae of epidermal necrolysis: risk factors during the acute phase and associated sequelae. (6th June 2019) Authors: Hajj, C.; Ezzedine, K.; Thorel, D.; Delcampe, A.; Royer, G.; Hua, C.; Colin, A.; de Prost, N.; Muraine, M.; Chosidow, O.; Wolkenstein, P.; Gueudry, J.; Ingen‐Housz‐Oro, S. Journal: British journal of dermatology Issue: Volume 181:Number 2(2019) Page Start: 421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Epidermal necrolysis and autoimmune diseases: two more observations supporting the concept that 'toxic' epidermal necrolysis can be 'non‐toxic'. (30th March 2018) Authors: Dumas, M.; Hua, C.; Hotz, C.; Velter, C.; Duong, T.A.; Maraffi, T.; Ortonne, N.; Hüe, S.; Fardet, L.; de Prost, N.; Wolkenstein, P.; Ingen‐Housz‐Oro, S.; Chosidow, O. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 9(2018) Page Start: e360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Factors which influence death rates in different types of epidermal necrolysis (drug reactions). (1st April 2020) Authors: Traikia, C.; Hua, C.; Le Cleach, L.; de Prost, N.; Hemery, F.; Bettuzzi, T.; Chosidow, O.; Wolkenstein, P.; Ingen‐Housz‐Oro, S.; Sbidian, E. Journal: British journal of dermatology Issue: Volume 182:Number 4(2020) Page Start: e147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗